Correlation of baseline 18F-FDG-PET/CT parameters with the outcome of advanced melanoma patients treated with the pd-1 blocking monoclonal antibody pembrolizumab
Gondry, O. (Speaker), Özdemir, I. (Contributor), Yanina Jansen (Contributor), Awada, G. (Contributor), Schwarze, J. K. (Contributor), Teofila Seremet (Contributor), Everaert, H. (Contributor), Neyns, B. (Contributor), Keyaerts, M. (Contributor)
Activiteit: Talk or presentation at a workshop/seminar